Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2020

01-07-2020 | Liver Transplantation | Original Article

Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation

Authors: Sasha Deutsch-Link, Robert M. Weinrieb, Lauren S. Jones, Steven F. Solga, Ethan M. Weinberg, Marina Serper

Published in: Digestive Diseases and Sciences | Issue 7/2020

Login to get access

Abstract

Background

Alcohol-related liver disease (ALD) is the leading indication for liver transplantation (LT) in the USA. Alcohol relapse post-LT can negatively impact long-term outcomes, and prognostic scoring systems are available for further study.

Aims

Our study aims were to: (1) evaluate the relationship between alcohol relapse and rejection and mortality, (2) investigate risk factors for relapse, and (3) assess predictive validity of the SIPAT (Stanford Integrated Psychosocial Assessment for Transplant) and SALT (Sustained Alcohol Use Post-Liver Transplant) scores on post-LT alcohol relapse.

Methods

We conducted a retrospective chart review of 155 patients transplanted for chronic ALD at a single transplant center. Cox proportional hazard models assessed the relationship between alcohol relapse and allograft rejection and psychosocial risk factors for relapse.

Results

20% of patients met criteria for alcohol relapse. Alcohol relapse was associated with allograft rejection (HR 2.33, 95% CI 1.11–4.91, p = .03). Three variables most strongly associated with alcohol relapse: prior relapse, failure to engage in recommended alcohol treatment, and continued drinking with liver disease, which were combined into a psychosocial model. SIPAT score≥ 21 and SALT score ≥ 7 were associated with alcohol relapse (HR 6.40, 95% CI 1.36–30.18, p = .019 and HR 2.30, 95% CI 1.12–4.75, p = .024). Receiver operator characteristic analysis compared predictive ability of our psychosocial model to SIPAT (C-statistic .83 compared to .71) and SALT (C-statistic = .77 compared to .62).

Conclusion

We identified important psychosocial predictors of post-LT alcohol relapse and validated SIPAT and SALT scores as pre-transplant risk factors for alcohol relapse.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: liver. Am J Transpl. 2014;14:69–96.CrossRef Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: liver. Am J Transpl. 2014;14:69–96.CrossRef
2.
go back to reference Augusto Marroni C, de Medeiros Fleck JA, Alves Fernandes S, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef Augusto Marroni C, de Medeiros Fleck JA, Alves Fernandes S, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef
3.
go back to reference Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the united states. Clin Gastroenterol Hepatol. 2018;16:1356–1358.PubMedCrossRef Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the united states. Clin Gastroenterol Hepatol. 2018;16:1356–1358.PubMedCrossRef
4.
go back to reference Kling CE, Perkins JD, Sibulesky L, Carithers RL, Donovan DM. Recent trends in liver transplantation for alcoholic liver disease in the United States Retrospective Cohort Study. World J Hepatol. 2017;9:1315–1321.PubMedPubMedCentralCrossRef Kling CE, Perkins JD, Sibulesky L, Carithers RL, Donovan DM. Recent trends in liver transplantation for alcoholic liver disease in the United States Retrospective Cohort Study. World J Hepatol. 2017;9:1315–1321.PubMedPubMedCentralCrossRef
5.
go back to reference Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005–2014. Drug Alcohol Depend. 2017;170:198–207.PubMedCrossRef Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005–2014. Drug Alcohol Depend. 2017;170:198–207.PubMedCrossRef
6.
go back to reference Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001–2016. JAMA. 2019;321:1723–1725.PubMedPubMedCentralCrossRef Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001–2016. JAMA. 2019;321:1723–1725.PubMedPubMedCentralCrossRef
7.
8.
go back to reference De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRefPubMed De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRefPubMed
9.
go back to reference Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transplant. 2007;13:197–205.CrossRef Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transplant. 2007;13:197–205.CrossRef
10.
go back to reference Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol. 2003;38:629–634.CrossRefPubMed Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol. 2003;38:629–634.CrossRefPubMed
11.
12.
go back to reference Moss AHSM. Should alcoholics compete equally for transplantation? JAMA. 1992;265:1295–1298.CrossRef Moss AHSM. Should alcoholics compete equally for transplantation? JAMA. 1992;265:1295–1298.CrossRef
13.
go back to reference Ubel PA. Transplantation in alcoholics: separating prognosis and responsibility from social biases. Liver Transplant Surg. 1997;3:343–346.CrossRef Ubel PA. Transplantation in alcoholics: separating prognosis and responsibility from social biases. Liver Transplant Surg. 1997;3:343–346.CrossRef
14.
go back to reference Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937.PubMedCrossRef Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937.PubMedCrossRef
15.
go back to reference Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med. 2019;179:340.PubMedPubMedCentralCrossRef Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med. 2019;179:340.PubMedPubMedCentralCrossRef
16.
go back to reference Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedPubMedCentralCrossRef Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedPubMedCentralCrossRef
17.
go back to reference Karim Z, Intaraprasong P, Scudamore CH, et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol Hepatol. 2010;24:245–250. Karim Z, Intaraprasong P, Scudamore CH, et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol Hepatol. 2010;24:245–250.
18.
go back to reference Maldonado J. SIPAT update: assessment of the performance of the Stanford Integrated Psychosocial Assessment for Transplantation during the post-transplant period. J Psychosom Res. 2016;85:73.CrossRef Maldonado J. SIPAT update: assessment of the performance of the Stanford Integrated Psychosocial Assessment for Transplantation during the post-transplant period. J Psychosom Res. 2016;85:73.CrossRef
19.
go back to reference Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score. Hepatology. 2019;69:1477–1487.PubMedPubMedCentralCrossRef Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score. Hepatology. 2019;69:1477–1487.PubMedPubMedCentralCrossRef
20.
go back to reference Thursz M, Gual A, Lackner C, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69:154–181.CrossRef Thursz M, Gual A, Lackner C, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69:154–181.CrossRef
21.
go back to reference Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65:217–224.PubMedCrossRef Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65:217–224.PubMedCrossRef
22.
go back to reference Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transplant Surg. 1999;5:318–331.CrossRef Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transplant Surg. 1999;5:318–331.CrossRef
23.
go back to reference Pizzo HP, Ettenger RB, Gjertson DW, et al. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. Pediatr Nephrol. 2016;31:2345–2352.PubMedCrossRef Pizzo HP, Ettenger RB, Gjertson DW, et al. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. Pediatr Nephrol. 2016;31:2345–2352.PubMedCrossRef
24.
go back to reference Del BA, Congy-Jolivet N, Danjoux M, et al. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol. 2018;24:1795–1802.CrossRef Del BA, Congy-Jolivet N, Danjoux M, et al. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol. 2018;24:1795–1802.CrossRef
25.
go back to reference Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.PubMedCrossRef Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.PubMedCrossRef
26.
go back to reference Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:e1. Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:e1.
27.
go back to reference Maldonado JR, Sher Y, Lolak S, et al. The Stanford Integrated Psychosocial Assessment for Transplantation. Psychosom Med. 2015;77:1018–1030.PubMedCrossRef Maldonado JR, Sher Y, Lolak S, et al. The Stanford Integrated Psychosocial Assessment for Transplantation. Psychosom Med. 2015;77:1018–1030.PubMedCrossRef
28.
go back to reference Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis—impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.PubMedCrossRef Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis—impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.PubMedCrossRef
29.
go back to reference Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transplant. 2004;10:S31–S38.CrossRef Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transplant. 2004;10:S31–S38.CrossRef
30.
go back to reference Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transplant. 2001;7:418–427.CrossRef Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transplant. 2001;7:418–427.CrossRef
31.
go back to reference DiMartini A, Weinrieb R, Fireman M. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am. 2002;25:195–209.PubMedCrossRef DiMartini A, Weinrieb R, Fireman M. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am. 2002;25:195–209.PubMedCrossRef
33.
34.
go back to reference O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367–2374.PubMedCrossRef O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367–2374.PubMedCrossRef
35.
go back to reference Sacco P, Sultan S, Tuten M, et al. Substance use and psychosocial functioning in a sample of liver transplant recipients with alcohol-related liver disease. Transplant Proc. 2018;50:3689–3693.PubMedCrossRef Sacco P, Sultan S, Tuten M, et al. Substance use and psychosocial functioning in a sample of liver transplant recipients with alcohol-related liver disease. Transplant Proc. 2018;50:3689–3693.PubMedCrossRef
36.
go back to reference Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology. 2011;54:1640–1649.PubMedCrossRef Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology. 2011;54:1640–1649.PubMedCrossRef
37.
go back to reference Weinrieb RM, Van Horn DHA, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transplant. 2011;17:539–547.CrossRef Weinrieb RM, Van Horn DHA, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transplant. 2011;17:539–547.CrossRef
38.
go back to reference Addolorato G, Mirijello A, Leggio L, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601–1608.PubMedPubMedCentralCrossRef Addolorato G, Mirijello A, Leggio L, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601–1608.PubMedPubMedCentralCrossRef
39.
go back to reference Weinrieb RM, Van Horn DHA, Mclellan AT, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001;42:110–116.PubMedCrossRef Weinrieb RM, Van Horn DHA, Mclellan AT, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001;42:110–116.PubMedCrossRef
40.
go back to reference Georgiou G. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transplant. 2003;9:772–775.CrossRef Georgiou G. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transplant. 2003;9:772–775.CrossRef
41.
go back to reference Peeraphatdit TB, Kamath PS, Karpyak VM, et al. Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2019;pii:S1542-3565. Peeraphatdit TB, Kamath PS, Karpyak VM, et al. Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2019;pii:S1542-3565.
42.
go back to reference Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922.PubMedCrossRef Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922.PubMedCrossRef
43.
go back to reference Leggio L, Lee MR. Treatment of alcohol use disorder in patients with alcoholic liver disease. Am J Med. 2017;130:124–134.PubMedCrossRef Leggio L, Lee MR. Treatment of alcohol use disorder in patients with alcoholic liver disease. Am J Med. 2017;130:124–134.PubMedCrossRef
44.
go back to reference Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014;38:2169–2177.PubMedPubMedCentralCrossRef Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014;38:2169–2177.PubMedPubMedCentralCrossRef
Metadata
Title
Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation
Authors
Sasha Deutsch-Link
Robert M. Weinrieb
Lauren S. Jones
Steven F. Solga
Ethan M. Weinberg
Marina Serper
Publication date
01-07-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05937-4

Other articles of this Issue 7/2020

Digestive Diseases and Sciences 7/2020 Go to the issue